Home » Topics » Regulatory » Patents

Patents
RSS

GH secretatogues from Fujisawa

July 8, 1998

New immunosuppressants from Merck & Co. acting on potassium channels

July 8, 1998

Inhibitors of protein kinase GSK3 prepared at Chiron, U. of California

July 8, 1998

Cor Therapeutics describes selective factor Xa inhibitors

July 8, 1998

PDE V inhibitors for heart failure, impotence claimed by Merck KGaA

July 8, 1998

Investigation at Kowa results in development of potent CysLT1 receptor antagonists

July 7, 1998

Series of MMP and TACE inhibitors patented by American Cyanamid

July 7, 1998

ACAT inhibitors from SS Pharm. for atherosclerosis

July 7, 1998

Taisho claims potent and selective D4 receptor antagonists

July 7, 1998

Carcinostatic agents developed at Toagosei

July 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...